BindingDB logo
myBDB logout

BDBM160211 US9040663, 57

SMILES: CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H]1CCCNC(=O)CC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O)C(N)=O

InChI Key: InChIKey=UCFQPBRLCMKTJY-BTFCHKKZSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 160211   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Melanocortin receptor 4


(Homo sapiens (Human))
BDBM160211
PNG
(US9040663, 57)
Show SMILES CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H]1CCCNC(=O)CC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O)C(N)=O
Show InChI InChI=1S/C50H69FN18O9/c1-27(70)63-35(9-5-19-59-49(53)54)43(73)65-36-10-4-18-58-41(71)17-16-34(42(52)72)64-47(77)39(22-29-24-61-33-8-3-2-7-32(29)33)68-44(74)37(11-6-20-60-50(55)56)66-46(76)38(21-28-12-14-30(51)15-13-28)67-48(78)40(69-45(36)75)23-31-25-57-26-62-31/h2-3,7-8,12-15,24-26,34-40,61H,4-6,9-11,16-23H2,1H3,(H2,52,72)(H,57,62)(H,58,71)(H,63,70)(H,64,77)(H,65,73)(H,66,76)(H,67,78)(H,68,74)(H,69,75)(H4,53,54,59)(H4,55,56,60)/t34-,35+,36-,37-,38+,39-,40-/m0/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

0.650n/an/an/an/an/an/an/an/a



AstraZeneca AB

US Patent


Assay Description
A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...


US Patent US9040663 (2015)


BindingDB Entry DOI: 10.7270/Q29885SK
More data for this
Ligand-Target Pair
Melanocyte-stimulating hormone receptor


(Homo sapiens (Human))
BDBM160211
PNG
(US9040663, 57)
Show SMILES CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H]1CCCNC(=O)CC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O)C(N)=O
Show InChI InChI=1S/C50H69FN18O9/c1-27(70)63-35(9-5-19-59-49(53)54)43(73)65-36-10-4-18-58-41(71)17-16-34(42(52)72)64-47(77)39(22-29-24-61-33-8-3-2-7-32(29)33)68-44(74)37(11-6-20-60-50(55)56)66-46(76)38(21-28-12-14-30(51)15-13-28)67-48(78)40(69-45(36)75)23-31-25-57-26-62-31/h2-3,7-8,12-15,24-26,34-40,61H,4-6,9-11,16-23H2,1H3,(H2,52,72)(H,57,62)(H,58,71)(H,63,70)(H,64,77)(H,65,73)(H,66,76)(H,67,78)(H,68,74)(H,69,75)(H4,53,54,59)(H4,55,56,60)/t34-,35+,36-,37-,38+,39-,40-/m0/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

1n/an/an/an/an/an/an/an/a



AstraZeneca AB

US Patent


Assay Description
A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...


US Patent US9040663 (2015)


BindingDB Entry DOI: 10.7270/Q29885SK
More data for this
Ligand-Target Pair